HIGHLIGHTS
- who: Siri Lillegraven et al. from the Medical School, Worcester, Massachusetts, United States of America, Corrona, LLC, Southborough, Massachusetts, United States of America, University of Alabama at Birmingham, Birmingham, AL, United have published the paper: Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0210459]. January 23, 2019 of December/24,/2018
- what: The aim of this study was to assess factors associated with incident diabetes in rheumatoid arthritis (RA). The authors assessed if choice of DMARDs and use of glucocorticoids is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.